Abstract
Purpose
The purpose of this paper is to develop a novel gastro-retentive osmotic pump capsule using asymmetric membrane technology.
Methods
The physical characteristics of capsule walls and drug delivery behaviors of the system were compared through different coating solutions. The formulation with the glycerin and diethyl phthalate ratio of 5:4 appears to be the best. The thickness of asymmetric membranes was evaluated by withdrawing speed. The relation between the two can be fitted to a linear model. The floating abilities were investigated through filling polyethylene oxide of different molecular weight into the capsules. WSR N-80 (molecular weight 200000) is chosen for the longest floating time. Central composite design-response surface methodology was used to investigate the influence of factors on the responses. The in vivo pharmacokinetics were studied in beagle dogs.
Results and conclusions
A second-order polynomial equation was fitted to the data, and the actual response values are in good accordance with the predicted ones. The optimized formulation displays a complete drug delivery, zero-order release rate and 12 h floating time. The in vivo study results clearly indicate the controlled and sustained release of Famotidine from the system, and the relative bioavailability of this preparation is about 1.605 in comparison to that of the marketed preparation.
Similar content being viewed by others
References
Liu LX, Xu XN. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet. Int J Pharm. 2007;10:1–6.
Liu LX, Khang G, Rhee JM, Lee HB. Monolithic osmotic tablet system for nifedipine delivery. J Controlled Release. 2000;67:309–22.
Chueh HR, Zia H, Rhodes CT. Optimization of sotalol floating and bioadhesive extended release tablet formulations. Drug Dev Ind Pharm. 1995;21:1725–47.
Iannuccelli V, Coppi G, Bernabei MT, Cameroni R. Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int J Pharm. 1998;174:47–54.
Desai S, Bolton S. A floating controlled-release drug delivery systems: in vitro–in vivo evaluation. Pharm Res. 1993;10:1321–5.
Thombre AG, Cardinal JR, et al. Asymmetric membrane capsules for osmotic drug delivery I. Development of a manufacturing process. J Control Release. 1999;57:55–64.
Wang CY, Ho HO, Lin LH, et al. Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects. Int J Pharm. 2005;297:89–97.
McCallum RW, Chremos AN, Kuljian B, et al. A novel histamine H2-receptor inhibitor with prolonged antisecretory effect. Dig Dis Sci. 1985;30:1139.
Thombre AG, Cardinal JR, et al. Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance. J Control Release. 1999;57:65–73.
Gan LC, Hou SX, Bi YQ, et al. Optimized preparation of tanshinones || A-loaded nanoparticles by central composite design and response surface method. Chi Pharm J. 2007;42:758–61.
K.M. Wagner. Like dissolves like. The 19th Biennial Conference on Chemical Education, West Lafayette; 2006.
Frasch HF, Barbero AM. Application of solid-phase microextraction to in vitro skin permeation experiments: example using diethyl phthalate. Toxicology in Vitro. 2005;19:253–9.
Liu JH, Ye L, Liu HS. Flow patterns of flow boiling of a highly viscous pseudoplastic fluid. Int C Heat Mass Transfer. 1995;22:359–67.
Cui FD. Pharmaceutics. 1st ed. Beijing: China Press of Chinese Medicine Technology; 2002.
Su DS, Wang SL. Physical Pharmaceutics. 1st ed. Beijing: Chemical Industry; 2004.
Buckman HO, Brady NC. The nature and property of soils—A college text of edaphology. 6th ed. New York: MacMillan; 1960.
Cao XP, Leyvaa N, Andersona SR, Hancocka BC. Use of prediction methods to estimate true density of active pharmaceutical ingredients. Int J Pharm. 2008;355:231–7.
POLYOX Water-Soluble Resins Dissolving Techniques. The Dow Chemical Company, Form No. 326-00002-0303 AMS; 2003.
Broda E. Limited and unlimited swelling of high molecular substances. Nature. 1938;142:116.
Tetsuya O, Hiroshi Y, Yoshio K. Control of medicine release from solid dispersion composed of the poly (ethylene oxide)-carboxyvinylpolymer interpolymer complex by varying molecular weight of poly (ethylene oxide). J Controlled Release. 1999;58:87–95.
Liu LX, Khang G, Rhee JM, Lee HB. Monolithic osmotic tablet system for nifedipine delivery. J Controlled Release. 2000;67:309–22.
Larsena SW, Østergaarda J, et al. Diflunisal salts of bupivacaine, lidocaine and morphine Use of the common ion effect for prolonging the release of bupivacaine from mixed salt suspensions in an in vitro dialysis model. Eur J Pharm Sci. 2007;31:172–9.
Lu EX, Jiang ZQ, Zhang QZ, Jiang XG. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic. suspending and expanding agent. J Controlled Release. 2003;92:375–82.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guan, J., Zhou, L., Pan, Y. et al. A Novel Gastro-Retentive Osmotic Pump Capsule Using Asymmetric Membrane Technology: In Vitro and In Vivo Evaluation. Pharm Res 27, 105–114 (2010). https://doi.org/10.1007/s11095-009-9984-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-009-9984-1